Research Coverage on Small and Micro-Cap Companies, Zacks Small Cap Research

Zacks Small Cap Research

Zacks Small Cap Research provides research coverage on small- and micro-cap companies that are “under-followed” or “under-valued” by Wall Street. We produce high quality equity research for the institutional and retail investor on microcap firms we believe are well positioned for future growth. The Zacks SCR analyst team has an average of 20 years of experience in investment research. We conduct significant due diligence in an effort to maintain the highest quality small-cap universe.

Research Coverage on Small and Micro-Cap Companies

Equity Bottom-Up

Actinium Pharmaceuticals  / Equity Bottom-Up

<ul><li>Actinium Pharmaceuticals is a biology-driven radiotherapy company advancing candidates in oncology and conditioning for solid tumors and hematological malignancies.</li><li>Its approach is expanding the reach of radiopharmaceuticals to novel target-isotope combinations in acute myeloid leukemia, solid tumors & conditioning.</li><li>It favors Ac-225 isotopes in its oncology pipeline and I-131 for conditioning candidates.</li></ul>

Actinium Pharmaceuticals is a biology-driven radiotherapy company advancing candidates in oncology and conditioning for solid tumors and hematological malignancies.Its approach is expanding the reach of radiopharmaceuticals to novel target-isotope combinations in acute myeloid leukemia, solid tumors & conditioning.It favors Ac-225 isotopes in its oncology pipeline and I-131 for conditioning candidates.

ATNM: Initiating Coverage - Diversified Nuclear Medicine Portfolio